Abstract
Apoptosis is a form of cell death that is mediated by specific biochemical cascades involving mitochondrial changes and activation of proteases called caspases. Apoptosis provides a mechanism for cells to die without adversely affecting their neighbors (Fig. 1). This contrasts with a nonregulated form of cell death called necrosis, in which cellular organelles swell and the plasma membrane becomes permeable, resulting in release of cellular contents and massive death of groups of cells throughout a tissue. Aberrant regulation of apoptosis may be the central abnormality in many different diseases, most prominent of which are cancers wherein cells become resistant to apoptosis. Therefore, a major effort in the field of cancer research is to identify the molecular alterations responsible for such cell immortalization (Wyllie, 1997).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albensi, B. C. and Mattson, M. P. (2000) Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35, 151–159.
Albensi, B. C., Sullivan, P. G., Thompson, M. B., Scheff, S. W., and Mattson, M. P. (2000) Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity. Exp. Neurol. 162, 385–389.
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., and Nicotera, P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961–973.
Barger, S. W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J., and Mattson, M. P. (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328–9332.
Beal, M. F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357–366.
Beer, R., Franz, G., Schopf, M., Reindl, M., Zelger, B., Schmutzhard, E., et al. (2000) Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow. Metab. 20, 669–677.
Bonventre, J. V., Huang, Z., Taheri, M. R., O’Leary, E., Li, E., Moskowitz, M. A., and Sapirstein, A. (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622–625.
Brandt, J., Bylsma, F. W., Gross, R., Stine, O. C., Ranen, N., and Ross, C. A. (1996) Trinucleotide repeat length and clinical progression in Huntington’s disease. Neurology 46, 527–531.
Bruce-Keller, A. J., Umberger, G., McFall, R., and Mattson, M. P. (1999) Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults [see comments]. Ann. Neurol. 45, 8–15.
Camandola, S. and Mattson, M. P. (2000) Pro-apoptotic action of PAR-4 involves inhibition of NF-kappa B activity and suppression of BCL-2 expression. J. Neurosci. Res. 61, 134–139.
Chan, S. L. and Mattson, M. P. (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167–190.
Choi, D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261–1276.
Clark, R. S., Kochanek, P. M., Chen, M., Watkins, S. C., Marion, D. W., Chen, J., et al. (1999) Increases in Bc1–2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. Faseb J. 13, 813–821.
Cookson, M. R. and Shaw, P. J. (1999) Oxidative stress and motor neurone disease. Brain Pathol. 9, 165–186.
Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N., and Beattie, M. S. (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73–76.
Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397.
Duan, W. and Mattson, M. P. (2000) Participation of Par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid. Exp. Neurol. 165, 1–11.
Duan, W. and Mattson, M. P. (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. J. Neurosci. Res. 57, 195–206.
Duan, W., Rangnekar, V. M., and Mattson, M. P. (1999a) Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72, 2312–2322.
Duan, W., Zhang, Z., Gash, D. M., and Mattson, M. P. (1999b) Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson’s disease. Ann. Neurol. 46, 587–597.
El-Agnaf, O. M., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., et al. (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloidlike filaments. FEBS Lett. 440, 71–75.
Emery, E., Aldana, P., Bunge, M. B., Puckett, W., Srinivasan, A., Keane, R. W., et al. (1998) Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89, 911–920.
Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang, L., Gomez-Isla, T., et al. (1998) Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18, 238–247.
Fox, G. B., Fan, L., Levasseur, R. A., and Faden, A. I. (1998) Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. J. Neurotrauma. 15, 599–614.
Fu, W., Begley, J. G., Killen, M. W., and Mattson, M. P. (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274, 7264–7271.
Fu, W., Killen, M., Culmsee, C., Dhar, S., Pandita, T. K., and Mattson, M. P. (2000) The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function [In Process Citation]. J. Mol. Neurosci. 14, 3–15.
Furukawa, K., Barger, S. W., Blalock, E. M., and Mattson, M. P. (1996) Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 74–78.
Furukawa, K., Fu, W., Li, Y., Witke, W., Kwiatkowski, D. J., and Mattson, M. P. (1997) The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178–8186.
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., et al. (1996) Func- tional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252–255.
Glazner, G. W., Chan, S. L., Lu, C., and Mattson, M. P. (2000) Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641–3649.
Green, D. R. and Reed, J. C. (1998) Mitochondria and apoptosis. Science 281, 1309–1312.
Guo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., and Mattson, M. P. (1999a) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5, 101–106.
Guo, Q., Fu, W., Xie, J., Luo, H., Sells, S. F., Geddes, J. W., et al. (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease [see comments]. Nat. Med. 4, 957–962.
Guo, Q., Sebastian, L., Sopher, B. L., Miller, M. W., Glazner, G. W., Ware, C. B., et al. (1999b) Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS 1 mutation. Froc. Natl. Acad. Sci. USA 96, 4125–4130.
Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin, G. M., and Mattson, M. P. (1997) Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212–4222.
Hagg, T. and Varon, S. (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA 90, 6315–6319.
Hu, S. C., Chrivia, J., and Ghosh, A. (1999) Regulation of CBP-mediated transcription by neuronal calcium signaling. Neuron 22, 799–808.
Jenner, P. and Olanow, C. W. (1998) Understanding cell death in Parkinson’s disease. Ann. Neurol. 44, S72–84.
Keller, J. N., Kindy, M. S., Holtsberg, F. W., St Clair, D. K., Yen, H. C., Germeyer, A., et al. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687–697.
Kim, M., Lee, H. S., LaForet, G., McIntyre, C., Martin, E. J., Chang, P., et al. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964–973.
Klevenyi, P., Andreassen, O., Ferrante, R. J., Schleicher, J. R., Jr., Friedlander, R. M., and Beal, M. F. (1999) Transgenic mice expressing a dominant negative mutant interleukin-lbeta converting enzyme show resistance to MPTP neurotoxicity. Neuroreport 10, 635–638.
Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619–642.
Kruman, H., Pedersen, W. A., Springer, J. E., and Mattson, M. P. (1999) ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160, 28–39.
Lee, J., Bruce-Keller, A. J., Kruman, Y., Chan, S., and Mattson, M. P. (1999) 2-Deoxy-Dglucose protects hippocampal neurons against excitotoxic and oxidative injury: involvement of stress proteins. J. Neurosci. Res. 57, 48–61.
Lee, J., Duan, W., Long, J. M., Ingram, D. K., and Mattson, M. P. (2000) Dietary restriction increases survival of newly-generated neural cells and induces BDNF expression in the dentate gyrus of rats. J. Mol. Neurosci. 15, 99–108.
Li, M., Ona, V. O., Guegan, C., Chen, M., Jackson-Lewis, V., Andrews, L. J., et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model [see comments]. Science 288, 335–339.
Liu, J. P. (1999) Studies of the molecular mechanisms in the regulation of telomerase activity. Faseb J. 13, 2091–2104.
Logroscino, G., Marder, K., Cote, L., Tang, M. X., Shea, S., and Mayeux, R. (1996) Dietary lipids and antioxidants in Parkinson’s disease: a population-based, case-control study. Ann. Neurol. 39, 89–94.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., and Cotman, C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951–7955.
Lu, C. and Mattson, M. P. (2000) Caspase-mediated degradation of AMPA receptors subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641–3649.
Mark, R. Murphy, J., Hensley, K., Butterfield, D. A., and Mattson, M. P. (1995) Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J. Neurosci. 15, 6239–6249.
Martin, L. J., Price, A. C., Kaiser, A., Shaikh, A. Y., and Liu, Z. (2000) Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review). Int. J. Mol. Med. 5, 3–13.
Martinou, J. C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., et al. (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017–1030.
Masliah, E., Mallory, M., Alford, M., Tanaka, S., and Hansen, L. A. (1998) Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 1041–1052.
Matsumoto, S., Friberg, H., Ferrand-Drake, M., and Wieloch, T. (1999) Blockade of the mitochondria) permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 19, 736–741.
Mattson, M. P. (1990) Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4, 105–117.
Mattson, M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081–1132.
Mattson, M. P. (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neuroscl. 21, 53–57.
Mattson, M. P. (2000) Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell Biol. 1, 120–129.
Mattson, M. P. and Camandola, S. (2000) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247–254.
Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) (3-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376–389.
Mattson, M. P. and Duan, W. (1999) “Apoptotic” biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 152–166.
Mattson, M. P. and Furukawa, K. (1998) Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples. Perspect. Dev. Neurobiol. 5, 337–352.
Mattson, M. P. and Keller, J. N. (1998) Neuroprotective actions of estrogen: a preventative and therapeutic approach for Alzheimer’s disease and stroke. Curr. Res. Alzheimer’s Dis. 3, 236–242.
Mattson, M. P., Keller, J. N., and Begley, J. G. (1998) Evidence for synaptic apoptosis. Exp. Neurol. 153, 35–48.
Mattson, M. P., LaFerla, F. M., Chan, S. L., Leissring, M. A., Shepel, P. N., and Geiger, J. D. (2000a) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222–229.
Mattson, M. P. and Lindvall, O. (1997) Neurotrophic factor and cytokine signaling in the aging brain, in The Aging Brain ( Mattson, M. P. and Geddes, J. W., eds.), JAI Press, Greenwich, CT, pp. 299–345.
Mattson, M. P., Pedersen, W. A., Duan, W., Culmsee, C., and Camandola, S. (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann. NY Acad. Sci. 893, 154–175.
Mattson, M. P., Zhu, H., Yu, J., and Kindy, M. S. (2000b) Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20, 1358–1364.
Mayeux, R., Costa, R., Bell, K., Merchant, C., Tung, M. X., and Jacobs, D. (1999) Reduced risk of Alzheimer’s disease among individuals with low calorie intake. Neurology 59, S296–297.
Middleton, G., Hamanoue, M., Enokido, Y., Wyatt, S., Pennica, D., Jaffray, E., et al. (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons [see comments]. J. Cell Biol. 148, 325–332.
Murakami, K., Kondo, T., Kawase, M., Li, Y., Sato, S., Chen, S. F., and Chan, P. H. (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18, 205–213.
Napieralski, J. A., Raghupathi, R., and McIntosh, T. K. (1999) The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res. Mol. Brain Res. 71, 78–86.
Ohlsson, A. L. and Johansson, B. B. (1995) Environment influences functional outcome of cerebral infarction in rats. Stroke 26, 644–649.
Oppenheim, R. W. (1991) Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453–501.
Pedersen, W. A., Luo, H., Kruman, I., Kasarskis, E., and Mattson, M. P. (2000) The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. Faseb J. 14, 913–924.
Pellegrini, M. and Strasser, A. (1999) A portrait of the Bcl-2 protein family: life, death, and the whole picture. J. Clin. Immunol. 19, 365–377.
Polymeropoulos, M. H. (1998) Autosomal dominant Parkinson’s disease and alpha-synuclein. Ann. Neurol. 44, S63–64.
Rigamonti, D., Bauer, J. H., De-Fraja, C., Conti, L., Sipione, S., Sciorati, C., et al. (2000) Wildtype huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705–3713.
Sanchez, I., Xu, C. J., Juo, P., Kakizaka, A., Blenis, J., and Yuan, J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats [see comments]. Neuron 22, 623–633.
Sastry, P. S. and Rao, K. S. (2000) Apoptosis and the nervous system. J. Neurochem. 74, 1–20.
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Jr., et al. (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 5, 1194–1198.
Schielke, G. P., Yang, G. Y., Shivers, B. D., and Betz, A. L. (1998) Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18, 180–185.
Senut, M. C., Suhr, S. T., Kaspar, B., and Gage, F. H. (2000) Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J. Neurosci. 20, 219–229.
Sinson, G., Perri, B. R., Trojanowski, J. Q., Flamm, E. S., and McIntosh, T. K. (1997) Improvement of cognitive deficits and decreased cholinergie neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury. J. Neurosurg. 86, 511–518.
Smith, R. G., Siklos, L., Alexianu, M. E., Engelhardt, J. I., Mosier, D. R., Colom, L., et al. (1996) Autoimmunity and ALS. Neurology 47, S40–S45; discussion S45 - S46.
Springer, J. E., Azbill, R. D., and Knapp, P. E. (1999) Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943–946.
Stein-Behrens, B., Mattson, M. P., Chang, I., Yeh, M., and Sapolsky, R. M. (1994) Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373–5380.
Su, J. H., Anderson, A. J., Cummings, B. J., and Cotman, C. W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer’s disease. Neuroreport 5, 2529–2533.
Sullivan, P. G., Geiger, J. D., Mattson, M. P., and Scheff, S. W. (2000) Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 48, 723–729.
Suzuki, T., Nishiyama, K., Yamamoto, A., Inazawa, J., Iwaki, T., Yamada, T., et al. (2000) Molecular cloning of a novel apoptosis-related gene, human Nap I (NCKAPI), and its possible relation to Alzheimer disease. Genomics 63, 246–254.
Tamatani, M., Ogawa, S., Nunez, G., and Tohyama, M. (1998) Growth factors prevent changes in Bc1–2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 5, 911–919.
Wada, S., Yone, K., Ishidou, Y., Nagamine, T., Nakahara, S., Niiyama, T., and Sakou, T. (1999) Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J. Neurosurg. 91, 98–104.
White, F. A., Keller-Peck, C. R., Knudson, C. M., Korsmeyer, S. J., and Snider, W. D. (1998) Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18, 1428–1439.
Wong, P. C., Rothstein, J. D., and Price, D. L. (1998) The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol. 8, 791–799.
Wyllie, A. H. (1997) Apoptosis and carcinogenesis. Eur. J. Cell Biol. 73, 189–197.
Yakovlev, A. G., Knoblach, S. M., Fan, L., Fox, G. B., Goodnight, R., and Faden, A. I. (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17, 7415–7424.
Yankner, B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16, 921–932.
Yu, Z. F. and Mattson, M. P. (1999) Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57, 830–839.
Yu, Z., Nikolova-Krakashian, M., Zhou, D., Cheng, G., Schuchman, E. H., and Mattson, M. P. (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal death. J. Mol. Neurosci. 15, 85–97.
Yu, Z., Zhou, D., Bruce-Keller, A. J., Kindy, M. S., and Mattson, M. P. (1999) Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19, 8856–8865.
Yu, Z., Zhou, D., Cheng, G., and Mattson, M. P. (2000) Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington’s disease. J. Mol. Neurosci. 15, 31–44.
Zhu, H., Fu, W., and Mattson, M. P. (2000) The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 75, 117–124.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mattson, M.P. (2001). Mechanisms of Neuronal Apoptosis and Excitotoxicity. In: Mattson, M.P. (eds) Pathogenesis of Neurodegenerative Disorders. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-106-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-106-0_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-215-5
Online ISBN: 978-1-59259-106-0
eBook Packages: Springer Book Archive